Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
UPCOMING SESSIONS
in
ET
Thu, Jun 11, 2026
5:00 – 6:00 AM Bangkok
What is the Role of Maintenance Treatment in AL Amyloidosis?
Ben Derman
Click To Register
View all
UPCOMING SESSIONS
in
ET
Thu, Jun 11, 2026 · 5:00 – 6:00 AM Bangkok
What is the Role of Maintenance Treatment in AL Amyloidosis?
Ben Derman
Click To Register
View all sessions
All Upcoming Sessions
3
JUN
11
What is the Role of Maintenance Treatment in AL Amyloidosis?
Thu, Jun 11, 2026 · 5:00 – 6:00 AM Bangkok
Ben Derman
Register
JUN
12
Courageous Optimism: Coping with Chronic Illness & Uncertainty
Fri, Jun 12, 2026 · 5:00 – 6:00 AM Bangkok
David Berez
Register
JUN
16
Advocacy 201: Using Your Experience to Improve Care for the Next Patient
Tue, Jun 16, 2026 · 5:00 – 6:00 AM Bangkok
David Gusick
Register
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial
Mar 30, 2026
News
Machine learning-based methods in diagnosing cardiac amyloidosis: A meta-analysis
Jun 08, 2026
‘Golden Years’ has won Silver in Healthcare & Pharma at The Drum Awards for Marketing for reframing ATTR-cardiac amyloidosis around possibility rather than decline. Here is the award-winning case study.
Jun 05, 2026
US FDA grants orphan drug designation to Attralus Therapeutic’s zamubafusp alfa for the treatment of AL amyloidosis
Jun 05, 2026
TTR protein clumps may help drive blood vessel damage in ATTR-CM
Jun 04, 2026
Transthyretin amyloid cardiomyopathy: Acoramidis reduces the risk of heart failure worsening by 41%.
Jun 04, 2026
More in News
Education
What is the diagnostic and treatment algorithm for amyloidosis, including evaluation, typing, and management of AL, ATTR, and AA forms?
Jun 05, 2026
Differential Diagnosis in ATTR-CM: 99mTc-PYP Scintigraphy and Diagnostic Workup
Jun 03, 2026
The Importance of Making ATTR-CM Terminology Accessible to Everyday People
Jun 02, 2026
Understanding ATTR-CM: A Powerful ConversationUnderstanding ATTR-CM: A Powerful Conversation
Jun 01, 2026
Hereditary transthyretin amyloidosis in African Americans: Challenges in diagnosis, patient education, and nursing implications
May 29, 2026
More in Education
Community Center
World Amyloidosis Day: Awareness and Support
Jun 05, 2026
heart_transplant_doc
Jun 05, 2026
amyloidosis_alliance
Jun 03, 2026
emiratescardiacsociety
Jun 02, 2026
What Is Transthyretin Amyloid Cardiomyopathy (ATTR-CM)?
Jun 01, 2026
More in Community Center
Video
